Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus (Q60462196)
Jump to navigation
Jump to search
scientific article published on 14 March 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus |
scientific article published on 14 March 2007 |
Statements
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus (English)
Berria R
Glass L
Mahankali A
Miyazaki Y
De Filippis E
Cusi K
Cersosimo E
14 March 2007